Drug
Opscf
Opscf: highest development phase Phase 2, developed by Insmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Insmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| OpSCF NCT06101823 | Phase 2 | Atopic Dermatitis |
Latest
No recent events.
Follow Opscf on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.